Federal Register Notice: FDA is seeking public comment on a proposed collection of information, the Study of Clinical Efficacy Information in Professional Labeling and Direct-to-Consumer (DTC) Print Advertisements for Prescription Drugs. The study will aim to investigate efficacy and effectiveness information of prescription drugs conveyed to healthcare providers through labeling and to consumers through print ads. Comments should be submitted by 8/16. To view this notice, click here.